|A large genome-wide association study of age-related macular degeneration highlights contributions of rare and common variants|
LG Fritsche, W Igl, JNC Bailey, F Grassmann, S Sengupta, ...
Nature genetics 48 (2), 134, 2016
|A germline DNA polymorphism enhances alternative splicing of the KLF6 tumor suppressor gene and is associated with increased prostate cancer risk|
G Narla, A DiFeo, HL Reeves, DJ Schaid, J Hirshfeld, E Hod, A Katz, ...
Cancer research 65 (4), 1213-1222, 2005
|The phenotypic legacy of admixture between modern humans and Neandertals|
CN Simonti, B Vernot, L Bastarache, E Bottinger, DS Carrell, RL Chisholm, ...
Science 351 (6274), 737-741, 2016
|Comparison of microsatellites versus single-nucleotide polymorphisms in a genome linkage screen for prostate cancer–susceptibility loci|
DJ Schaid, JC Guenther, GB Christensen, S Hebbring, C Rosenow, ...
The American Journal of Human Genetics 75 (6), 948-965, 2004
|Nonparametric tests of association of multiple genes with human disease|
DJ Schaid, SK McDonnell, SJ Hebbring, JM Cunningham, SN Thibodeau
The American Journal of Human Genetics 76 (5), 780-793, 2005
|A Combined Genomewide Linkage Scan of 1,233 Families for Prostate Cancer–Susceptibility Genes Conducted by the International Consortium for Prostate Cancer Genetics|
J Xu, L Dimitrov, BL Chang, TS Adams, AR Turner, DA Meyers, RA Eeles, ...
The American Journal of Human Genetics 77 (2), 219-229, 2005
|Comparison of RNA-seq and microarray-based models for clinical endpoint prediction|
W Zhang, Y Yu, F Hertwig, J Thierry-Mieg, W Zhang, D Thierry-Mieg, ...
Genome biology 16 (1), 133, 2015
|Glycine and a Glycine Dehydrogenase (GLDC) SNP as Citalopram/Escitalopram Response Biomarkers in Depression: Pharmacometabolomics‐Informed …|
Y Ji, S Hebbring, H Zhu, GD Jenkins, J Biernacka, K Snyder, M Drews, ...
Clinical Pharmacology & Therapeutics 89 (1), 97-104, 2011
|Two common chromosome 8q24 variants are associated with increased risk for prostate cancer|
L Wang, SK McDonnell, JP Slusser, SJ Hebbring, JM Cunningham, ...
Cancer Research 67 (7), 2944-2950, 2007
|Evaluation of genetic variations in the androgen and estrogen metabolic pathways as risk factors for sporadic and familial prostate cancer|
JM Cunningham, SJ Hebbring, SK McDonnell, MS Cicek, GB Christensen, ...
Cancer Epidemiology and Prevention Biomarkers 16 (5), 969-978, 2007
|Human SULT1A1 gene: copy number differences and functional implications|
SJ Hebbring, AA Adjei, JL Baer, GD Jenkins, J Zhang, JM Cunningham, ...
Human molecular genetics 16 (5), 463-470, 2006
|A PheWAS approach in studying HLA-DRB1*1501|
SJ Hebbring, SJ Schrodi, Z Ye, Z Zhou, D Page, MH Brilliant
Genes and immunity 14 (3), 187, 2013
|The gene for HMSN2C maps to 12q23-24: a region of neuromuscular disorders|
CJ Klein, JM Cunningham, EJ Atkinson, DJ Schaid, SJ Hebbring, ...
Neurology 60 (7), 1151-1156, 2003
|The challenges, advantages and future of phenome‐wide association studies|
Immunology 141 (2), 157-165, 2014
|Opportunities for drug repositioning from phenome-wide association studies|
M Rastegar-Mojarad, Z Ye, JM Kolesar, SJ Hebbring, SM Lin
Nature biotechnology 33 (4), 342, 2015
|Glutathione S-transferase T1 and M1: gene sequence variation and functional genomics|
AM Moyer, OE Salavaggione, SJ Hebbring, I Moon, MAT Hildebrandt, ...
Clinical Cancer Research 13 (23), 7207-7216, 2007
|No association of germline alteration of MSR1 with prostate cancer risk|
L Wang, SK McDonnell, JM Cunningham, S Hebbring, SJ Jacobsen, ...
Nature genetics 35 (2), 128, 2003
|Confirmation of linkage of prostate cancer aggressiveness with chromosome 19q|
SL Slager, DJ Schaid, JM Cunningham, SK McDonnell, AF Marks, ...
The American Journal of Human Genetics 72 (3), 759-762, 2003
|FKBP5 genetic variation: association with selective serotonin reuptake inhibitor treatment outcomes in major depressive disorder|
KA Ellsworth, I Moon, BW Eckloff, BL Fridley, GD Jenkins, A Batzler, ...
Pharmacogenetics and genomics 23 (3), 156, 2013
|Pharmacogenomics of selective serotonin reuptake inhibitor treatment for major depressive disorder: genome-wide associations and functional genomics|
Y Ji, JM Biernacka, S Hebbring, Y Chai, GD Jenkins, A Batzler, KA Snyder, ...
The pharmacogenomics journal 13 (5), 456, 2013